Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Click here to subscribe.
While there are other stem cell drugs on the market, such as Neurostem and Promostem, Cartistem sets itself apart as the “World’s First Allogeneic, Off-the-Shelf, Stem Cell Drug”
Learn how an extensible ontology can advance your research goals. Learn how an ontology defines the issues most important to the patient or research subject such as diseases, operations, medications, lab results and outcomes, allowing for a detailed analysis of patient experience over an extended period of time.
On March 6, 2020, the U.S. Food and Drug Administration announced that it had classified the Becton Dickinson Alaris System infusion pump recall as a Class I recall, the agency’s most severe recall for medical devices that could cause serious injury or death.
Paragonix Technologies is developing transport devices that supply organs with oxygen and nutrients.
Paragonix is also developing transport devices for the lung, pancreas, kidney and liver designed to improve donor organ quality and extend donor organ preservation time. Cardiac transplantation is considered the gold-standard therapy for patients in end-stage heart failure.
In three years, 157 hospitals participating in the Premier healthcare alliance’s QUEST®: High Performing Hospitals national collaborative have saved an estimated 24,820 lives and reduced healthcare spending by nearly $4.5 billion.
The American Medical Association, the Florida Medical Association and the Florida Osteopathic Medical Association are calling on Florida Attorney General Pam Bondi to reject the proposed merger of health insurer giants Aetna and Humana, according to a March 14 release from the AMA.
Florida Blue, the state’s Blue Cross and Blue Shield company, has announced today it will invest $7 million into its community for COVID-19 relief, more than tripling its initial donation.
Donating blood helps save lives and has positive benefits for donors, such as improving their emotional and physical health. People who donate blood may also experience side effects, such as minor bruising or feeling lightheaded.
The global Blood Bank Reagents Market research report gives point to point breakdown along with the data of Blood Bank Reagents market’s analytical study, regional analysis, growth factors and leading companies. The research report about the market provides the data about the aspects which drive the expansion of Blood Bank Reagents industry.
Ivera Medical has received 510(k) clearance from the FDA for its Curos disinfecting port protector meant to minimize the risk.
The American Red Cross, America’s Blood Centers and AABB have issued a joint statement encouraging individuals to donate blood and convalescent plasma during the month of January.
Florida insurance regulators have approved Aetna’s acquisition of Humana’s affiliates there, but with conditions, according to a consent order issued last week.
Ten people have been indicted in connection to a scheme of using rural hospitals across multiple states to allegedly bill private insurance companies for fraudulent laboratory testing claims.
The Humana Foundation is investing $1.84 million to address the social determinants of health in Knoxville, Tennessee, and Jacksonville, Florida.
Cigna has teamed up with Integrated Independent Physicians Network in Florida for an accountable care organization model that rewards doctors for having a healthier population and saving money.
A proposed Senate resolution calls for lawmakers to place a state constitutional amendment question on the ballot in 2022, asking voters to require a two-thirds majority margin of the Florida Legislature to enact any measure installing a single-payer health care system in the state.